Organocopper
Search Within Results
61
–
75
of
141
results
61
Medchemexpress LLC DOTA-EB-TATE | 2151063-66-8 | 95.4% | 2329.63 | 5 MG
This peptide drug conjugate (PDC) is composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to improve the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity, and can also be utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs).
- Composed of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB)
- Improves pharmacokinetics of SSTR2 analogs
- Reduces PRRT toxicity
- Utilized for the synthesis and research of Radionuclide-Drug Conjugates (RDCs)
62
Medchemexpress LLC DOTA-EB-TATE | 2151063-66-8 | 95.4% | 2329.63 | 1 MG
DOTA-EB-TATE is a peptide drug conjugate (PDC) consisting of an SST peptide derivative, DOTA-octreotate, conjugated to an Evans blue analog (EB). It is designed to enhance the pharmacokinetics of SSTR2 analogs and reduce PRRT toxicity.
- Enhances pharmacokinetics of SSTR2 analogs
- Reduces PRRT toxicity
- Useful for synthesis and research of Radionuclide-Drug Conjugates (RDCs)
- Functions as a peptide drug conjugate (PDC)
- Applicable in cancer targeted therapy
- Used in cancer metabolism and metastasis research
63
64
65
66
67
68
69
70
71
72
73
74
75
eMolecules 1317-39-1 | Copper(i) oxide | Combi-Blocks | MFCD00010974 | 143.091 | Cu2O | 97.000 | [O--].[Cu+].[Cu+] | 5g | 335346415
Copper(i) oxide | Combi-Blocks | 1317-39-1 | MFCD00010974 | 143.091 | Cu2O | 97.000 | [O--].[Cu+].[Cu+] | 5g | 335346415